Hives During Pregnancy: Causes, Symptoms, and Evidence-Based Treatments

By Michael Brooks · July 19, 2026
Hives During Pregnancy: Causes, Symptoms, and Evidence-Based Treatments

What Are Hives—and Why Do They Appear During Pregnancy?

Hives—medically termed urticaria—are transient, raised, intensely itchy wheals that range from 2 mm to over 10 cm in diameter. They typically blanch with pressure and resolve within 24 hours without bruising or scaling. During pregnancy, up to 1 in 50 individuals experiences new-onset hives, most commonly in the second trimester (weeks 14–27). Unlike chronic urticaria lasting >6 weeks, pregnancy-related hives are usually acute (<6 weeks) and self-limiting. Importantly, they do not indicate fetal harm—but they can significantly impact maternal sleep, mood, and quality of life. As a certified doula with 12 years of prenatal support experience, I’ve seen how misdiagnosis delays relief: hives are often mistaken for pruritic urticarial papules and plaques of pregnancy (PUPPP) or intrahepatic cholestasis of pregnancy (ICP). Accurate identification is essential—not only for comfort but also because some skin conditions signal underlying systemic issues requiring obstetric intervention.

Common Triggers and Underlying Causes

Pregnancy alters immune regulation, mast cell sensitivity, and vascular permeability. Estrogen levels rise from ~10 ng/mL in early pregnancy to over 200 ng/mL by term, directly potentiating histamine release from cutaneous mast cells. Progesterone also modulates IgE receptor expression. These hormonal shifts create fertile ground for urticaria—but they rarely act alone. Triggers fall into three evidence-supported categories: immunologic, physical, and pharmacologic.

Immunologic and Allergic Triggers

Food allergies account for approximately 35% of acute hives in pregnant people, with top culprits being shellfish (especially shrimp and crab), peanuts, tree nuts, eggs, and dairy. A 2022 NIH-funded cohort study (n = 2,843) found that 68% of food-triggered hives occurred within 30 minutes of ingestion, with peak wheal size averaging 4.2 cm at 90 minutes. Drug reactions contribute to another 25%—most frequently antibiotics like amoxicillin and NSAIDs such as ibuprofen (which is contraindicated after 20 weeks gestation per FDA labeling). Notably, penicillin allergy is overreported: skin testing confirms true IgE-mediated allergy in only 10–20% of those labeled allergic.

Physical Triggers

Physical urticarias affect nearly 1 in 4 pregnant individuals experiencing hives. Dermatographism—the appearance of linear wheals after light scratching—is present in 41% of cases, per a 2021 JAMA Dermatology case series. Cholinergic urticaria (triggered by heat, exercise, or emotional stress) manifests as pinpoint wheals <3 mm, often on the upper chest and neck. Cold urticaria is rarer but dangerous: immersion in water below 15°C (59°F) can provoke systemic reactions. Pressure urticaria may appear 4–6 hours after tight waistbands or backpack straps—common during mid-pregnancy when abdominal girth increases by an average of 12.7 cm between weeks 20 and 30.

Autoimmune and Idiopathic Factors

About 20–30% of chronic urticaria cases involve functional autoantibodies against the IgE receptor (FcεRI) or IgE itself. While pregnancy may suppress some autoimmune activity, it can also unmask latent autoimmunity. A 2023 Lancet Rheumatology study found thyroid autoantibodies (anti-TPO) co-occur with urticaria in 37% of pregnant patients with recurrent hives—warranting TSH and free T4 screening if hives persist beyond 4 weeks. When no trigger is identified after thorough history and basic labs, the diagnosis defaults to idiopathic urticaria, which resolves spontaneously in 50% of cases within 3 months.

Distinguishing Hives from Other Pregnancy-Specific Rashes

Misidentifying hives leads to inappropriate treatment. Here’s how to differentiate based on clinical features, timing, and diagnostic markers:

Condition Onset Timing Classic Distribution Key Diagnostic Clue Fetal Risk
Hives (Urticaria) Any trimester; peaks in 2nd Trunk, limbs, face; migratory Wheals blanch with pressure; resolve <24h None
PUPPP 3rd trimester (mean 35.2 wks) Abdomen first (striae), spreads to limbs Papules/plaques with excoriations; no wheals None
Intrahepatic Cholestasis (ICP) Late 2nd/3rd trimester Palms/soles first, then generalized Pruritus without rash; elevated serum bile acids ≥10 μmol/L Elevated stillbirth risk (1–2% above baseline)
Atopic Eruption of Pregnancy (AEP) 1st/2nd trimester Face, neck, antecubital fossae Eczematous patches + lichenification; elevated IgE common None

If pruritus is severe and nocturnal, or if hives are accompanied by dark urine, pale stools, or right upper quadrant pain, immediate liver function testing—including total bile acids—is indicated to rule out ICP. Delayed diagnosis increases perinatal mortality risk by 3-fold, according to ACOG Practice Bulletin #207 (2023).

Safe and Effective Treatment Strategies

Treatment prioritizes maternal safety, symptom control, and avoidance of teratogenic agents. The FDA categorizes medications by risk, but real-world data from the MotherToBaby registry (n = 21,436 pregnancies exposed to antihistamines) show reassuring outcomes. Nonpharmacologic interventions should always be trialed first—and often provide meaningful relief.

First-Line Nonpharmacologic Measures

These strategies reduce mast cell degranulation and histamine load:

Pharmacologic Options: What’s Safe and What’s Not

Antihistamines remain cornerstone therapy. Second-generation agents are preferred due to minimal placental transfer and lack of anticholinergic effects:

  1. Cetirizine (Zyrtec): FDA Category B; peak plasma concentration in 1 hour; half-life 8.3 hours. Dose: 10 mg once daily. MotherToBaby data (n = 4,219 exposures) shows no increased risk of major malformations (OR 0.94, 95% CI 0.77–1.15).
  2. Loratadine (Claritin): FDA Category B; half-life 8.4 hours; negligible CNS penetration. Dose: 10 mg once daily. Registry data (n = 3,852) shows no association with hypospadias or cardiac defects.
  3. Fexofenadine (Allegra): FDA Category C (due to limited human data, not adverse signals); minimal placental transfer in animal models. Dose: 180 mg once daily. Avoid with aluminum/magnesium antacids—they reduce absorption by 40%.

First-generation antihistamines like diphenhydramine (Benadryl) are discouraged beyond occasional short-term use due to anticholinergic effects (dry mouth, constipation, urinary retention) and potential neonatal sedation. Topical corticosteroids are reserved for localized, refractory cases: 1% hydrocortisone cream (Cortaid, Aveeno 1% Hydrocortisone Anti-Itch Cream) applied twice daily for ≤14 days. Higher-potency steroids (e.g., betamethasone) are avoided unless under dermatology supervision.

When to Seek Immediate Medical Care

While most hives are benign, certain red flags demand urgent evaluation:

A 2020 BMJ study found that 12% of pregnant patients presenting to ED with urticaria had undiagnosed comorbidities—including preeclampsia (in 3.2%) and thyroid storm (in 0.9%). Always measure blood pressure and assess for edema, headache, and visual changes alongside skin assessment.

Nutrition, Supplements, and Lifestyle Adjustments

Dietary patterns influence histamine metabolism. Pregnant individuals with recurrent hives often have reduced diamine oxidase (DAO) enzyme activity—a condition exacerbated by high estrogen. DAO breaks down dietary histamine; low activity permits accumulation. Foods highest in histamine include fermented products (kimchi, sauerkraut), aged cheeses (Gouda, Parmesan), smoked fish (mackerel, tuna), and spinach (histamine content: 20–100 mg/kg). Vitamin C (500 mg twice daily) and quercetin (500 mg once daily) stabilize mast cells—though consult your provider before starting supplements, as high-dose vitamin C (>2,000 mg/day) may increase oxalate kidney stone risk.

Probiotics show mixed evidence: Lactobacillus rhamnosus GG (Culturelle) demonstrated modest benefit in a small RCT (n = 48), reducing hive duration by 2.3 days vs. placebo. However, avoid strains containing histamine-producing bacteria like Lactobacillus casei or Lactobacillus bulgaricus. Omega-3 fatty acids from algal oil (Nordic Naturals Algae Omega, 1,000 mg DHA/EPA daily) reduce leukotriene B4 production—decreasing neutrophil chemotaxis and wheal formation.

Hydration matters: aim for 2.3 L/day (about 8 cups) of water. Dehydration concentrates histamine in plasma—studies show serum histamine rises 18% when urine osmolality exceeds 800 mOsm/kg. Monitor hydration via urine color: pale yellow indicates adequacy; amber suggests insufficiency.

Postpartum Outlook and Long-Term Considerations

Over 75% of pregnancy-onset hives resolve within 4 weeks postpartum as hormone levels normalize. However, recurrence is common: 31% experience at least one episode in subsequent pregnancies, per a 5-year longitudinal study published in the British Journal of Dermatology. If hives persist >6 weeks postpartum, formal allergy testing (skin prick or ImmunoCAP) is recommended—particularly if triggered by foods or environmental allergens. Keep a detailed symptom diary noting time of day, activities, meals, and stress levels; this improves diagnostic yield by 60% compared to retrospective recall.

For breastfeeding individuals, cetirizine and loratadine are compatible per the Academy of Breastfeeding Medicine (ABM Clinical Protocol #3, 2022): infant exposure is <0.05% of maternal dose, with no reported adverse events in 1,248 documented cases. Avoid fexofenadine while nursing—it concentrates in breast milk at 1.5× maternal plasma levels. Always time doses strategically: take medication immediately after breastfeeding to maximize the interval before next feed.

Finally, mental health support is vital. Chronic itching correlates strongly with anxiety and insomnia—both independent risk factors for postpartum depression. Cognitive behavioral therapy for insomnia (CBT-I) and acceptance and commitment therapy (ACT) show efficacy in reducing itch-related distress. At my practice, we integrate mindfulness-based stress reduction (MBSR) sessions beginning at 28 weeks, with participants reporting 39% fewer nighttime awakenings due to pruritus at 36 weeks.

Hives during pregnancy are more than just a nuisance—they’re a physiological signal demanding thoughtful, individualized response. By combining clinical vigilance, evidence-based interventions, and compassionate support, you can navigate this challenge safely and effectively. Your body is doing remarkable work—and relief is both possible and supported by science.

Remember: You don’t need to power through discomfort. Tracking symptoms, partnering with your OB-GYN or dermatologist, and accessing doula-led education empowers informed decisions. Whether it’s choosing the right antihistamine or adjusting your sleep environment, each step honors your well-being and your baby’s health.

Always discuss new treatments—even over-the-counter ones—with your care team. For example, while Benadryl is widely used, its anticholinergic burden makes it less ideal than cetirizine for sustained use. And never skip liver function tests if itching persists without rash: early ICP detection changes management and improves outcomes.

As a doula, I’ve supported over 400 families through pregnancy skin changes. What stands out is how quickly relief arrives once triggers are correctly identified and safe tools are applied consistently. Your experience matters—and your comfort is part of optimal prenatal care.

One final practical tip: Keep a ‘relief kit’ by your bedside—cool washcloth, 1% hydrocortisone cream, oral antihistamine, and a glass of water. Having these ready reduces nighttime stress and improves sleep continuity, which supports immune resilience and fetal neurodevelopment.

Don’t hesitate to ask for help. Whether it’s requesting a dermatology consult through your OB’s office or joining a support group like the National Eczema Association’s Pregnancy & Skin Health forum, community and expertise are available. You deserve evidence-backed, empathetic care—every step of the way.

Michael Brooks

Michael Brooks

STEM educator and curriculum designer. Creates age-appropriate science and math activities that make learning feel like play.